Ten prior healthcare exits across the bench (5 NASDAQ IPOs, 5 M&As). A $15B nationwide healthcare initiative led on the operating side.
Senior advisors — a former senior economic advisor to the FDA and CMS (and ex-Acting Chair of the White House CEA), and a former Dell Global Healthcare CTO.
Why we exist
YCare is building the national infrastructure to deliver healthcare innovation where patients live — combining licensed home-health agencies, advanced digital-health technology, AI-enabled workflows, and clinical excellence to bring the latest care into the homes of Medicare, Medicaid, and high-need populations.
We are inviting operators, advisors, clinicians, technologists, and capital partners who share our principles to help us build YCare the right way — from the very beginning.
How we build
What we will not compromise on. What we expect of every partnership, every hire, every acquisition.
Every clinical, technology, and operating decision grounded in evidence. We generate real-world evidence from the home setting because healthcare must be measured by what works for patients — not by what sounds good in a deck.
We exist for the patients the system has historically underserved — Medicare, Medicaid, and high-need populations. Every member of YCare is hired for capability and for the conviction that better care for these patients is the work that matters most.
The home-health sector is shaped by long compliance cycles. We build EVV, billing rigor, and regulatory transparency into the foundation — not as a layer added later. This is how we earn the trust of health systems, payers, and CMS.
YCare is AI-native from the ground up. Care coordination, clinical workflows, patient engagement, and quality measurement are built with AI as core — not as add-on. We integrate the best digital-health tools across the industry into a single deployment platform that scales.
We do not compete with health systems, payers, or providers — we partner with them. YCare is built to be the partner of choice for institutions serving patients beyond their walls, with the latest technology and the highest standards of care.
CEO & Chair
Healthcare tech executive and investor with 9 exits, including 5 NASDAQ IPOs and 4 M&As. Co-Founder & Managing Partner of ATEM Capital. Previously executed $20B+ in M&A/IPO transactions at Barclays Capital and Dresdner Kleinwort.
Founder, Chief Strategy Officer & CTO
30+ year technology executive with a PhD in Mathematics and Mathematical Economics. Built and exited a 200-nurse home-healthcare operation through M&A in 2010; previously held senior technology roles at Motorola, Bell Labs, and Citigroup.
COO
Former Senior Partner at McKinsey & Company (25+ years). Led a $15B nationwide healthcare initiative in Colombia. Former member of the Wharton Executive Board.
Chief Clinical Officer
30+ year cardiopulmonary clinician and home-health leader. Former national VP in specialty pharmacy and biotech; built at-home transplant and heart-failure programs, led UF Health’s clinical trials, and brings premium home-care operator experience.
VP of Sales
30+ year technology sales and services executive. Former Motorola VP of Sales and Services, where he led a $160M business and drove growth across the Americas.
A uniquely positioned team — operator-deep, clinically credentialed, enterprise-tech native, policy-fluent — built to be a reliable, compliant partner.
Advisory Board
Former senior economic advisor to the FDA Commissioner and the CMS Administrator; former Acting Chair, White House Council of Economic Advisers. UChicago Harris School of Public Policy.
Advisory Board
Former CEO of Baylor Scott & White Health and THA Legends Award honoree. Led the Baylor–Scott & White merger, creating Texas’s largest not-for-profit health system; 11-time Modern Healthcare 100 Most Influential People in Healthcare honoree.
Board Director
Managing Partner, ATEM Capital.
Board Director
Former Global Healthcare CTO, Dell Technologies. Anchors enterprise technology strategy.
Operators complemented by a team of stellar and engaged advisors on the federal policy, enterprise tech, and strategic capital.